[ET Net News Agency, 30 May 2023] CLOVER BIO-B (02197) fell 2.38% to HK$1.23.
It hits an intra-day low of HK$1.22, hitting a historical low, and an intra-day high of
HK$1.28. The total shares traded was 3.32 million, with a value of HK$4.16m. The active
buy/sell ratio is 47:53, with net selling turnover of HK$284,860. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$541,459, with volume
weighted average price of HK$1.257. MORGAN STANLEY HK SEC accounts for greatest net
responsive selling turnover of HK$404,886, with volume weighted average price of HK$1.26.
The stock has fallen a combined 12.14% over the past 3 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 1.230 % Chg -2.38%
High 1.280 Low 1.220
Shares Tr 3.32m Turnover 4.16m
10-D SMA 1.431 %H.V 73.072
20-D SMA 1.568 VWAP 1.254
50-D SMA 1.725 RSI14 27.238
--------------------------------
Status: Hitting a historical low, active buy/sell ratio is 47:53, with net selling
turnover of HK$284,860, falling a combined 12.14% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CLOVER BIO-B (02197) 1.23 -2.38
HUTCHMED (00013) 19.54 -1.81
GENSCRIPT BIO (01548) 17.48 +0.46
INNOVENT BIO (01801) 35.50 +0.85
KEYMED BIO-B (02162) 40.15 +4.02
WUXI BIO (02269) 41.80 -0.48
BEIGENE (06160) 140.50 +1.74
AKESO (09926) 32.90 -0.15
ALPHAMAB-B (09966) 7.87 -1.38
REMEGEN-B (09995) 33.40 -2.62
---------------------------------------------
(ed)